The Commission has today put forward proposals to ensure the continued long-term supply of medicines from Great Britain to Northern Ireland and to address outstanding supply concerns in Cyprus, Ireland and Malta. This means that the same medicines will continue to be available in Northern Ireland at the same time as in the rest of the United Kingdom, while specific conditions ensure that UK-authorised medicines do not enter the Single Market.
The proposed bespoke solution reflects the outcome of substantial discussions between Vice-President Maroš Šefčovič and the United Kingdom Cabinet Office Minister, David Frost, and takes into account the concerns raised by stakeholders during the Commission’s extensive outreach.
With today’s proposed solution, the Commission is delivering on its intention to facilitate the implementation of the Protocol on Ireland/Northern Ireland on the ground, in line with the package of far-reaching solutions for Northern Ireland tabled on 13 October 2021.
More information is available online:
- Statement by Vice-President Šefčovič
- Press release
- Q&A
Follow the press conference with Vice-President Šefčovič and Commissioner Kyriakides live on EbS